Immediate Impact
1 by Nobel laureates 16 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD
2024 Standout
Works of Serena Aneli being referenced
Liver Cancer-Specific Isoform of Serine Protease Inhibitor Kazal for the Detection of Hepatocellular Carcinoma: Results from a Pilot Study in Patients with Dysmetabolic Liver Disease
2022
Biomarkers of Oncogenesis, Adipose Tissue Dysfunction and Systemic Inflammation for the Detection of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Serena Aneli | 98 | 77 | 37 | 26 | 226 | |
| Ana María Inda | 41 | 75 | 70 | 31 | 298 | |
| Tanya N. Augustine | 25 | 65 | 23 | 33 | 254 | |
| EM Pagliaro | 107 | 120 | 34 | 17 | 250 | |
| Kelly S. Levano | 74 | 123 | 7 | 20 | 291 | |
| E. R. Eller | 128 | 28 | 43 | 20 | 269 | |
| Alexandra Trinks | 64 | 118 | 18 | 15 | 271 | |
| Ulises Toscanini | 204 | 68 | 41 | 32 | 255 | |
| Yuwen Pan | 99 | 83 | 15 | 28 | 226 | |
| Xiaomin Yang | 176 | 101 | 40 | 28 | 226 | |
| Ralph Garcia‐Bertrand | 197 | 68 | 45 | 31 | 278 |
All Works
Login with ORCID to disown or claim papers
Loading papers...